Ocugen Inc. (NASDAQ: OCGN) is a biopharmaceutical company focused on discovering, developing, and commercializing gene therapies to cure blindness diseases and developing a vaccine to fight COVID-19.
REVOLUTION Medicines
18 followers
Halozyme Therapeutics
10 followers
SpringWorks Therapeutics
10 followers
BillionToOne
7 followers
Immunovant
7 followers
Dyne Therapeutics
6 followers
Stemline Therapeutics
4 followers
Beta Bionics
4 followers
Arcutis Biotherapeutics
3 followers
ADMA Biologics
3 followers
Abeona Therapeutics
3 followers
Precigen
3 followers